Senators passed a bill May 29 that adds substances and compounds to the Schedule I controlled substances list.
In order to be classified as a Schedule I drug under federal law, a drug or substance must have a high potential for abuse, lack an accepted safe use under medical supervision and have no currently accepted medical treatment use in the United States. No prescriptions may be written for Schedule I controlled substances and they are subject to production quotas by the federal Drug Enforcement Administration (DEA).
LB298, introduced by Omaha Sen. Beau McCoy, makes adamantoylindoles, tetramethylcyclopropanoylindoles, adamantylindole carboxamides, phenethylamine, tryptamine and their compounds Schedule I controlled substances.
The bill passed with an emergency clause on a 44-2 vote.